H&H International Holdings (01112) subsidiary has been granted approximately $320 million in term loan financing and approximately $10 million in revolving credit financing.

Zhito Finance APP news, H&H International Holdings (01112) announced that on August 5, 2026, the company and Biostime Healthy Australia Investment Pty Ltd (a wholly-owned subsidiary of the company) (as the original borrower) entered into a syndicated financing agreement (refinancing credit agreement) with Hongkong and Shanghai Banking Corporation Limited (as agent and security agent) to provide term loan financing equivalent to approximately USD 320 million (term loan financing); and revolving credit financing equivalent to approximately USD 10 million (revolving financing, collectively referred to as "refinancing credit" with term loan financing), with a total amount equivalent to approximately USD 330 million.